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Abstract
Polygala senega is extensively used in traditional systems of medicine against various 
lung diseases including cancer. In the present study we tested the anticancer poten-
tials of ethanolic extract of roots of P. senega (generally used as a homeopathic drug) 
in a mammalian model, where mice, in vivo, were treated chronically with benzo[a]
pyrene and in vitro where lung adenocarcinoma cell line (A549) were used. We 
deployed various parameters like cell viability assay, chromatin condensation stud-
ies with Hoechst 333258 staining, and maintained suitable controls. To understand 
the possible signal transduction pathways, expression of various signal proteins 
such as Aryl Hydrocarbon receptor (AhR), cytochrome P450 (CYP1A1), Bcl-2, prolif-
erating cell nuclear antigen (PCNA), Bax and Caspase-3 was studied. Additionally, 
reverse transcriptase polymerase chain reaction analysis of AhR, p53, PCNA and 
β-actin (housekeeping) genes was made. Immunohistochemical localization of PCNA 
proteins was also conducted in vivo. Feeding of root extract of P. senega to mice 
(at the rate of 50 mg/kg and 100 mg/kg bw) chronically treated with the carcinogen 
(50 mg/kg bw dissolved in olive oil) showed positive modulation in expression of 
signal proteins. Upregulation of apoptotic signals such as p53, Caspase-3 and Bax, 
and downregulation of AhR, cytochrome P450 (CYP1A1), Bcl-2 and PCNA were 
observed. Addition of root extract of Polygala Senega (at doses of 50 μg and 100 μg) 
into culture medium containing A549 cells induced recovery of decreased cell via-
bility and increased chromatin fragmentation (apoptosis).Therefore, results of both 
in vivo and in vitro studies scientifically validate its potential use as an anticancer 
agent, particularly against lung cancer, and provide important information potentially 
helpful in drug designing.
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1.  Introduction
Lung cancer is the most common cause of cancer-
related death in both men and women, accounting 
for 29% of all cancer deaths [1]. It is characterized 
by its poor prognosis and resistance to the apopto-
sis activity of antineoplastic drugs both in vivo and 
in vitro [2,3]. In light of the very poor survival rates 
of lung cancer patients, new therapeutic approaches 
are therefore necessary [4].
At present, surgery and chemotherapy are the 
main modes of treatment for most cancers but in 
case of lung cancer treatment outcome by these 
procedures is limited due to frequent recurrences. 
Therefore current approaches for control of lung 
cancer focus mainly on prevention. An alternative 
way of practical approach could be through chemo-
prevention by intake of selected food items and 
beverages. Some plants, vegetables, herbs and spices 
used in folk and traditional medicines have become 
subjects of great interest for investigation to see if 
they really possess anticancer properties that can 
be scientifically validated and recommended for 
possible therapeutic use against cancer [5]. Polygala 
senega is used in western herbal medicine as an 
expectorant to treat cough, sore throat, bronchitis 
and asthma [6,7]. The antihypoglycemic effect of 
P. senega was investigated in normal and KK-Ay mice 
[8]. The saponins of P. senega are used as vaccine 
adjuvants to increase specific immune responses 
[9]. P. senega also possesses anti-inflammatory prop-
erties when tested in a RAW 264.7 macrophage cell 
system [10], but its efficacy as an anticancer agent 
against lung cancer has not been tested. However, 
we felt that more controlled in vivo as well as in 
vitro studies are warranted to verify its reported 
anticancer effects in model biological systems, which 
had not been done earlier. Further, it is also neces-
sary to focus on its mechanism of action, if it is 
found to have anticancer effect.
In the present study, the hypotheses tested were 
to see (1) if root extract of P. senega could induce 
cytotoxicity and cause cell death in normal primary 
culture of lung cells of mice; (2) if it did, what 
could be the safe dose that does not cause any cy-
totoxicity in normal lung cells; (3) if the treatment 
of P. senega extract could cause cytotoxicity and 
chromatin fragmentation (apoptosis) in cultured 
adenoma cell line A549; (4) if it did, what could be 
the optimum dose that caused the maximum effect; 
(5) if tested positive in in vitro studies, whether 
extract of P. senega can also be effective in vivo, 
in mice chronically treated with benzo[a]pyrene 
to develop hyperplasia in lung; (6) whether signal 
transduction pathways can be modulated; and (7) 
whether modulation in regulatory signal proteins is 
also reflected in DNA ladder.
Both in vitro and in vivo models were chosen in 
the present study; experiments were so designed 
to ascertain if root extract of P. senega has anti-
cancer properties that could be of therapeutic value 
as a chemopreventive nontoxic drug.
2.  Materials and Methods
2.1.  Reagents
Benzo[a]pyrene was purchased from Sigma-Aldrich 
Inc. (St-Louis, MO, USA); Aryl hydrocarbon receptor 
(AhR) and proliferating cell nuclear antigen (PCNA) 
mouse monoclonal antibody (primary antibody) were 
purchased from Abcam Inc. (Cambridge, MA, USA). 
Caspase-3 and bax (Primary antibody) were pur-
chased from BD Biosciences (Franklin Lakes, NJ, 
USA). Cytochrome P450 (CYP1A1), p53, Bcl-2 (pri-
mary antibody) and anti-mouse (secondary antibody) 
were purchased from Santa Cruz Biotechnology 
Inc. (San Francisco, CA, USA). Dulbecco’s modified 
Eagle’s medium (DMEM), fetal bovine serum, penicil-
lin, streptomycin, neomycin (PSN) antibiotic, trypsin 
and ethylenediaminete traacetic acid (EDTA) were 
purchased from Gibco BRL (Grand Island, NY, USA). 
Tissue culture plastic wares were obtained from BD 
Biosciences. All organic solvents used were of high 
performance liquid chromatography grade. MTT [3-
(4,5-Dimethyl-thiazol-2-yl)-2, S-diphenyltetrazolium 
bromide] and all other chemicals used were pur-
chased from Sigma-Aldrich Inc.
2.2. Preparation of crude extract
The extract of root of P. senega was procured from 
Schwabe GmbH, Karlsruhe, Germany. During the 
process of preparation, dried plant roots were 
macerated with 48% alcohol and filtered. Filtrate 
was evaporated to a thick residue at 50ºC. The 
yield of the extract was about 60%. The extract 
was re-suspended in 48% alcohol and used for in 
vitro and vivo experiments.
2.3.  Cell culture
The cell line A549 (human nonsmall lung carcinoma) 
cells were obtained from National Centre for Cell 
Science, Pune, India. Cells were cultured in DMEM 
supplemented with 10% fetal bovine serum, and 1% 
PSN antibiotic at 37ºC in a humidified incubator 
with 5% CO2. Cells were harvested with 0.025% 
trypsin and 0.52 mM EDTA in phosphate buffered 
saline and plated at required cell numbers and al-
lowed to adhere for 24 hours before treatment. 
Cultures of 0.5−1.0 × 105 cells/mL were used for the 
experiments.
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2.4.  Dose for cultured cells
Cells (A549 and isolated lung) were treated with 
different doses of root extract of P. senega (50 μg, 
100 μg, 200 μg and 400 μg) for different periods of 
time, that is, 24 hours, 48 hours and 72 hours.
2.5.  A549 cell culture
The human lung A549 cells were obtained from the 
National Centre for Cell Science, Pune, India. A549 
cells from one vial (containing approximately 105 
cells) were thawed rapidly by immersing in a 37ºC 
water bath. The cells were transferred to a 15 mL 
centrifuge tube containing 10 mL DMEM and re-
suspended by gentle aspiration with a pipette. After 
centrifugation for 10 minutes at 1000 rpm, the super-
natant was removed and the cells were re-suspended 
in complete medium supplemented with 10% heat-
inactivated fetal calf serum, 1% nonessential amino 
acids with a pH of 7.4. The well-grown cells were 
harvested and seeded into 96-well plates at a den-
sity of 2 × 105 cells/mL for experiments.
2.6.  Isolation and primary culture of 
lung cell
Lung was removed from mice aseptically followed 
by addition of collagenase. Single cell suspensions 
were made in DMEM by passing the cell population 
through a nylon mesh with 50-μm pore size. After 
the preparation of single cell suspension by passing 
through nylon mesh, the cell suspension was incu-
bated at 37°C. Then MTT assay was performed.
2.7.  MTT assay
Cell viability was assessed using MTT assay as de-
scribed by Mosmann [11]. A549 and isolated lung 
cells (105 cells/mL) were cultured for 24 hours on 
96-well microplates. After that cells were incubated 
for 72 hours with or without the drug. The control 
received no drug. Absorbance was measured at 
595 nm by enzyme-linked immunoabsorbant assay. 
Cell survival rate was calculated as the percentage of 
MTT inhibition as follows: percentage of survival = 
(mean experimental absorbance/mean control 
absorbance) × 100%.
2.8.  Hoechst 33258 staining
Apoptotic nuclear morphology was assessed using 
Hoechst 33258 staining as described by Chen et al. 
[12] with slight modification. Hoechst 333258 (1 μg/
mL) was added for 5 minutes, and cells were ex-
amined by fluorescence microscope (Axiscope plus 
2; Carl Zeiss, Oberkochen, Germany).
2.9.  DNA ladder analysis
For DNA laddering assay, cells were harvested into 
extraction buffer (10 mM Tris-HCL pH 7.4, contain-
ing 10 mM NaCl, 20 mM EDTA and 1% Triton X-100). 
Geno mic DNA was isolated by digesting the cell ex-
tract with 10 μg/mL of proteinase K at 56ºC for 
8−12 hours. DNA was purified by phenol/chloro-
form precipitated with ethanol and dissolved in 
Tris-EDTA. Integrity of DNA was analyzed by gel 
electrophoresis on 1% agarose gels followed by 
ethidium bromide staining.
2.10. Feeding procedure for mice
Each mouse was fed 100 μL of either root extract 
of P. senega or double distilled water with the aid 
of a fine pipette as per requirement of a particular 
series.
2.11. Animals
Healthy Swiss albino mice weighing 20−25 g (8−
10 weeks old) were reared in the animal house of 
the Department of Zoology, University of Kalyani. 
The animals were kept in plastic cages under hygi-
enic conditions and were provided standard animal 
feed. Necessary approvals were obtained from the 
Institutional Ethical Committee.
2.12.  Experimental protocol
The experimental animals were divided into five 
groups, each group comprising six animals:
Group 1 served as normal olive oil control. Group 
2 animals were administered with benzo[a]pyrene 
(50 mg/kg bw dissolved in olive oil, orally) twice a 
week for 4 successive weeks to induce lung cancer 
by 16th week [13]. Group 3 was fed benzo[a]pyrene 
as in group 2 and 48% alcohol as the drug (root extract 
of P. senega) was dissolved in 48% alcohol; this served 
as the alcohol control. Group 4 animals were fed 
50 mg/kg bw of root extract of P. senega 1 day before 
the first dose of benzo[a]pyrene administration and 
continued for 16 weeks. The treatment was used to 
study the chemopreventive effects of root extract 
of P. senega, if any, in the experimental animals. 
Group 5 animals were treated with 100 mg/kg bw of 
extract for 16 weeks as in group 4.
2.13. Immunohistochemistry of PCNA
After having sacrificed the mice from all groups, lungs 
from each mouse were collected, washed in phos-
phate buffered saline and soaked in blotting paper to 
remove the blood. Tissues were then fixed in 10% 
neutral buffered formalin for 24 hours. The tissue 
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samples were dehydrated in ascending concentra-
tions of ethanol, cleared in xylene, and embedded in 
paraffin to prepare the block. The 6 μm serial sec-
tions were used in such a way that the corresponding 
sections were used for immunohistological evalua-
tion. Immunohistochem istry was performed follow-
ing the methods used by Ramakrishnan et al [14].
2.14.  Protein extraction and western blot 
analysis
Protein was isolated for the analysis by western blot. 
For protein isolation, lungs were collected from all 
groups, homogenized in lysis buffer [15]. The ho-
mogenized material was centrifuged at 13,000g for 
15 minutes at 4ºC; the supernatant known as cyto-
plasmic extract was removed. This cytosolic super-
natant was analyzed with western blot and the 
amount of protein was quantified with the Lowry 
method. Western blot analysis was performed as de-
scribed previously [16]. For quantitative analysis of 
each band, density was determined using Gel Doc 
System (UltraLum Inc., Claremont, CA, USA).
2.15.  Real-time polymerase chain reaction 
(RT-PCR) for the detection of mRNA 
expression of different genes
Total RNA was extracted from the lung tissue using 
Trizol reagent according to the manufacturer’s in-
structions (Bangalore GeNei P Ltd., Karnataka, 
India) Following PCR, 5-μL sample aliquots were 
subjected to electrophoresis on 1% (w/v) agarose 
gel [17] for 20−30 min and then stained with ethid-
ium bromide and photographed. The primer se-
quences of amplified genes are shown in Table 1. 
Densitometry was performed using Total Lab soft-
ware (TotalLab Ltd., Newcastle, UK). β-actin mRNA 
was amplified as loading control.
2.16.  Statistical analysis
Statistical analysis of the data was performed by 
student t test. A p < 0.05 was considered significant. 
Table 1  Primer sequences of cancer-related genes 
used
Primer name Primer sequences
β-actin*  Catalogue number-117816,GeNei
AhR F: AAGCATGCAGAACGAGGAGT
 R: CCAACCCTCACAGTTCTGGT
PCNA*  Catalogue number-117813,GeNei
p53*  Catalogue number-117810,GeNei
*Purchased from Bangalore GeNei P Ltd. AhR = Aryl hydrocar-
bon receptor; PCNA = proliferating cell nuclear antigen.
For all quantitative analyses, data were expressed as 
mean values obtained from triplicate experiments 
(on blot and immunohistochemistry studies) showing 
SE and levels of significance.
3. Results
3.1.  Cell-viability studies in primary mice 
lung cells
In order to investigate the cell cytotoxicity in long-
term-cultured lung cells, medium described above 
was supplemented with various doses of root ex-
tract of P. senega. After 24 hours, 48 hours and 72 
hours of incubation at various doses as shown in 
Table 2, a dose-dependent cell viability by MTT assay 
were also found in cultured primary mice lung cells, 
where cells viability dropped slightly with increasing 
doses of P. senega extract.
3.2. Cell-viability studies in A549 cells
After about 24 hours of culture when cells reached 
60−70% confluence, unattached cells were re-
moved by gentle agitation and the medium was 
changed to medium containing various doses of 
root extract of P. senega (50 μg, 100 μg, 200 μg and 
400 μg) or vehicle (alcohol) for control. As shown 
in Table 2, the addition of root extract of P. senega 
to A549 cell culture resulted in dose-dependent 
cell viability after 24 hours, 48 hours and 72 hours 
of exposure. Although no apparent cytotoxic ef-
fect on cell viability was observed at lower doses 
(50 μg, 100 μg and 200 μg), at higher dose (400 μg), 
root extract of P. senega was more toxic to A549 
cells than to mice lung cells (normal) with respect 
to time.
3.3.  Hoechst 333258 staining
To examine the biological findings of apoptosis in 
A549 cells induced by root extract of P. senega, 
Hoechst staining was performed. As shown from 
Hoechst staining, some nuclei of the root extract 
treated cells (Figure 1) exhibited typical features 
of apoptosis such as nuclear condensation.
3.4.  DNA damage by DNA laddering
DNA fragmentation data as revealed from the DNA 
ladders in agarose gel electrophoresis are presented 
in Figure 2. As compared to the control, the frag-
mentation in 50 μg, 100 μg and 200 μg treated cells 
appeared to be more smeared, indicating greater 
DNA fragmentation suggestive of greater degree of 
apoptosis.
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3.5.  Immunohistochemical analysis of
PCNA protein on lung
Our next attempt was to determine the impact of 
root extract of P. senega on the expression of genes 
Table 2  Effect of different doses of root extract of Polygala senega on cell viability of isolated lung cells and 
A549 cells by MTT assay in a dose-dependent and time-dependent manner
Cell viability of isolated lung cells by MTT assay
Series 24-hr 48-hr 72-hr
Control 100 ± 0.00 100 ± 0.00 100 ± 0.00
Control + alcohol 94.66 ± 1.20  90.0 ± 1.73 88.33 ± 0.882
50 μg 91.0 ± 1.73* 87.33 ± 1.85* 80.6 ± 2.7*
100 μg 85.0 ± 2.1† 83.0 ± 1.52† 74.66 ± 2.4‡
200 μg 84.0 ± 1.52‡ 79.0 ± 1.8† 70.66 ± 1.76§
400 μg 82.0 ± 1.15‡ 72.66 ± 1.45‡ 50.33 ± 1.5§
Cell viability of A549 cells by MTT assay
Series 24-hr 48-hr 72-hr
Control 100 ± 0.00 100 ± 0.00 100 ± 0.00
Control + alcohol 97.0 ± 2.1 95.33 ± 1.85 93.66 ± 0.882
50 μg 81.0 ± 2.8† 70.66 ± 2.8‡ 65.0 ± 1.15§
100 μg 75.33 ± 2.4‡ 63.33 ± 1.5§ 47.33 ± 1.45‡
200 μg 70.33 ± 2.5‡ 52.0 ± 1.73§ 39.66 ± 3.18§
400 μg 50.33 ± 2.5§ 37.33 ± 1.45§ 18.33 ± 2.5§
*Not significant; †p < 0.05; ‡p < 0.01; §p < 0.001, significance represents significant difference from alcohol control treated series.
Control + alcohol
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Figure 1 Fluorescence photomicrographs of A549 cells with Hoechst 33258 staining. The assessment of nuclear mor-
phology of the cell was performed after A549 cells were incubated for 24 hours, 48 hours and 72 hours with vehicle 
(alcohol) and with root extract of Polygala senega (50 μg, 100 μg and 200 μg). Arrows indicate nuclear fragmentation.
associated with cell proliferation. Immunohistochem-
ical staining for PCNA in the lung of control and 
experimental group of animals (Figure 3). Benzo[a]
pyrene and alcohol fed group 3 animals showed a 
significant increase in the number on PCNA positive 
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nuclei when compared with group 1 normal control 
animals, while root extract of P. senega treatment 
significantly decreased the number of PCNA posi-
tive nuclei when compared with benzo[a]pyrene 
and alcohol fed animals.
3.6.  Expression of AhR and CYP1A1 on
lung cancer
AhR and CYP1A1 gene expression were measured in 
the lungs of mice after induction lung cancer by 
16th week. The expression level of AhR and CYP1A1 
was found to be downregulated in the drug-treated 
group, whereas expression of AhR and CYP1A1 protein 
from lung tissues of tumor-bearing mice (benzo[a]
pyrene fed) are upregulated (Figure 4A).
3.7.  Effect of root extract of P. senega on 
expression of proapoptotic and 
antiapoptotic proteins
After confirming that root extract of P. senega in-
duces apoptosis during lung carcinogenesis, our 
next attempt was to determine the impact of the 
extract on the expression of genes associated with 
apoptosis. As it is well established that various 
proapoptotic and antiapoptotic proteins play a cru-
cial role in programmed cell death, we examined 
whether or not the root extract of P. senega can 
affect the expression of proapoptotic protein, Bax 
as well as antiapoptotic protein, Bcl-2 in our mice 
model. Interestingly, it was observed that the ex-
tract could elevate the expression of Bax in the 
1Lane 2 3 4 5
Figure 2 Effect of root extract of Polygala senega on 
A549. A549 cells were treated with different doses of 
drugs for 24 hours. Genomic DNA was extracted and DNA 
was separated on 1% agarose gel and stained with ethidium 
bromide. Lane 1 contains a standard DNA ladder, lane 2 
contains DNA from untreated cells, lane 3 contains DNA 
from drug (50 μg), lane 4 contains DNA from drug (100 μg) 
and lane 5 from drug-treated (200 μg) cells.
benzo[a]pyrene-fed mice and as shown in Figure 4A. 
Bcl-2 expression was found to be downregulated by 
the root extract at the same stage of carcinogenesis 
(on the 16th weeks).
3.8.  Effect of root extract of P. senega on 
Caspase-3 expression
After assessing that root extract of P. senega in-
creased the Bax expression, our next interest was 
to see whether it increased the levels of Caspase-3 
expression via upregulation of Bax expression or not. 
Interestingly it was found that it increased Caspase-3 
expression on the 16th weeks (Figure 4A).
3.9.  Gene expression by root extract of
P. senega in benzo[a]pyrene
treated mice
mRNA expression of different gene such as AhR, p53 
and PCNA, have been shown in (Figure 4B). The data 
also normalized with β-actin. The expression of AhR 
and PCNA have been downregulated by the root 
extract at a dosage of 50 mg/kg and 100 mg/kg body 
weight, respectively, whereas the expression level 
of p53 was upregulated after the drug treatment.
4. Discussion
Cancer chemoprevention has become an important 
area of cancer research. There is compelling clinical 
and epidemiological evidence that dietary constit-
uents [18] are associated with reduced risk of can-
cer including precancerous lesions of the buccal 
mucosa, second primary tumors in patients treated 
for squamous cell carcinoma of the head and neck 
[19], and lung. Experimental studies have revealed 
that the process of carcinogenesis can be modulated 
by timely intervention including administration of 
chemopreventive agent [20] or intake of protective 
agents through regular food and drinks.
In the present study, the root extract of P. senega 
at doses of 200 μg and 400 μg caused cytotoxicity 
and cell death in a significant number of normal cul-
ture cells. However, lower doses of 50 μg and 100 μg 
were found to be relatively nontoxic to the lung 
cells in primary culture, while they significantly sup-
pressed the proliferation of A549 cells in culture. 
Moreover, the nuclear morphology analyzed quan-
titatively by Hoechst 33258 suggested that an ap-
optotic cell death mechanism was also potentially 
involved in the direct cytotoxicity of the cancer cell 
line. On the other hand, in vivo studies demonstrated 
that benzo[a]pyrene is a major carcinogenic constitu-
ent in tobacco smoke [21] which is metabolically 
activated by the CYP system to reactive diolepoxides 
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that are capable of interacting with DNA or proteins 
to form adducts. In the lung, CYP1A1 and CYP1B1 
are important in the biotransformation of benzo[a]
pyrene. In the present investigation, downregula-
tion of CYP1A1 was observed after treatment of the 
root extract of P. senega, suggesting that it inhibited 
DNA adduct formation.
Results of the current study imply that root ex-
tract of P. senega interfere with the process of pro-
grammed cell death through modulation of caspase-3 
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Figure 3 Immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in the lung of control and exper-
imental groups of animals. (A−E) The lung sections of groups 1−5 experimental animals respectively. (F) Histogram 
representing the percentage of PCNA-positive cells in control and experimental groups. *p < 0.05. Arrow represents 
PCNA-positive cells. (A) Group 1: Normal (olive oil); (B) Group 2: benzo[a]pyrene + olive oil; (C) Group 3: benzo[a] 
pyrene + olive oil + alcohol; (D) Group 4: benzo[a]pyrene + olive oil + 50 mg/kg bw of root extract of Polygala senega; 
(E) Group 5: benzo[a]pyrene + olive oil + 100 mg/kg bw of root extract of P. senega.
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expression. The expression of p53 protein is con-
nected with cell DNA damage. Derangements of p53 
protein expression are the most often observed le-
sions in the invasive types of lung cancer [22] and 
seem to play a vital role in the multidegree pathway 
of cancerous lesion development [23].
Bcl-2 protein has antiapoptotic qualities. Bcl-2 
overexpression in atypical adenomatous hyperpla-
sia cells is significant and reaches about 70% [24]. 
The antiapoptotic activity of Bcl-2 correlates with 
its intracellular ratio to Bax. It was reported that 
p53 induces apoptosis by either increasing tran-
scriptional activity of proapoptotic genes such as 
Bax or suppressing the activity of the antiapoptotic 
gene of the Bcl-2 family [25]. RT-PCR and Western 
blot findings revealed that root extract of P. senega 
suppressed AhR mRNA and protein expression levels 
compared with those of the control. This finding 
demonstrates the antiapoptotic activity of root ex-
tract of P. senega associated with the downregula-
tion of AhR expression.
The extract of P. senega did not significantly in-
duce toxicity or cause any mortality in the treated 
normal mice. In animals bearing lung hyperplasia, 
the significant tumor progression may be due to the 
uncontrolled proliferation of lung cells. On drug 
treatment, regression of tumors might have been 
due direct inhibitory action of the drug on tumor 
growth. PCNA is a 36 kDa auxiliary protein to DNA 
polymerase-S, which is found in various concentra-
tions within the cell throughout the cell cycle and 
in greatest quantities during the S-phase [26]. De-
creased expression of PCNA upon treatment of drug 
revealed the antiproliferative effect of root extract 
of P. senega. This might help prevent cancer cells 
from proliferation. The principal active constituents 
of P. senega are saponin glycosides polygalic acid 
and senegin, which make up 5% and 4% of the dried 
root, respectively [27]. Earlier studies have revealed 
P. senega to have immune system stimulating ac-
tivity, but not much evidence exists for its antican-
cer effects [28,29]. Findings of the present study 
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Figure 4 (A) Western blot analysis shows the effect of root extract of Polygala senega on the expression of β-actin, 
Aryl hydrocarbon receptor (AhR), cytochrome P450 (CYP1A1), Bcl-2, Bax, Caspase-3, proliferating cell nuclear anti-
gen (PCNA) during mouse lung carcinogenesis induced by benzo[a]pyrene. mRNA expression of AhR, p53, PCNA with 
internal control β-actin. *p < 0.05; †p < 0.01; ‡p < 0.01. Lane 1: normal; lane 2: benzo[a]pyrene + olive oil; lane 3: 
benzo[a]pyrene + olive oil + alcohol; lane 4: benzo[a]pyrene + olive oil + 50 mg/kg bw of root extract of P. senega; lane 
5: benzo[a]pyrene + olive oil + 100 mg/kg bw of root extract of P. senega. Histogram represents the band densities 
expressed as mean ± SE of the three independent experiments.
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suggest that they also have considerable antican-
cer potentials against lung cancer.
The results obtained in the present study demon-
strated that root extract of P. senega has apoptotic 
potential on A549 cell in vitro and benzo[a]pyrene-
induced lung carcinogenesis in vivo with minor cyto-
toxic effects in primary lung cells.
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